NIO: It’s Getting Interesting (NYSE:NIO)NIO: It’s Getting Interesting (NYSE:NIO)
Robert Way While China’s electric vehicle [EV] manufacturer NIO Inc. (NYSE:NIO) had an expectedly weak past quarter on the stock[...]
Author: Manika Premsingh
Waldencast: Price Can Fall Further For Now, But Medium Term Potential Exists (WALD)Waldencast: Price Can Fall Further For Now, But Medium Term Potential Exists (WALD)
leszekglasner/iStock via Getty Images The cosmetics company Waldencast (NASDAQ:WALD) has had a bad 2024 at the stock markets so far,[...]
Roche Stock: Obesity Treatment’s Promise Isn’t Enough (OTCMKTS:RHHBY)Roche Stock: Obesity Treatment’s Promise Isn’t Enough (OTCMKTS:RHHBY)
FilippoBacci The Swiss pharmaceutical stock Roche Holding AG (OTCQX:RHHBY) might have seen underwhelming performance year-to-date [YTD], but a turnaround is[...]
Christian Dior: Capital Appreciation Unlikely For Now (CHDRF)Christian Dior: Capital Appreciation Unlikely For Now (CHDRF)
winhorse Luxury fashion stock Christian Dior (OTCPK:CHDRF) (OTCPK:CHDRY) has been a good long-term buy for investors going for capital appreciation.[...]
AstraZeneca: The Price Upside Is Exhausted For Now (Rating Downgrade) (NASDAQ:AZN)AstraZeneca: The Price Upside Is Exhausted For Now (Rating Downgrade) (NASDAQ:AZN)
Robert Way Since I last wrote about the UK based pharmaceuticals company AstraZeneca (NASDAQ:AZN) in March, its price is up[...]